Sign In
Buy CABA
$3.58
-0.100 (-2.72%)
At Close: Jun 03, 2026
4 Drug Stocks That More Than Doubled This Year
10:32am, Friday, 30'th Dec 2022
We present four biotech stocks, AVEO, CABA, VRNA and WVE, which despite the current volatile market, have provided more than twice the returns in 2022.
Can Cabaletta Bio, Inc. (CABA) Climb 60% to Reach the Level Wall Street Analysts Expect?
11:17am, Wednesday, 07'th Dec 2022
The mean of analysts' price targets for Cabaletta Bio, Inc. (CABA) points to a 60% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement amon
Cabaletta Bio to Present at the 5th Annual Evercore ISI HealthCONx Conference
08:00am, Tuesday, 22'nd Nov 2022
PHILADELPHIA, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapie
5 Penny Stocks To Buy According To Analysts, Targets Up To 992%
01:33pm, Monday, 14'th Nov 2022
Analysts say these are penny stocks to buy. Do you agree?
5 Stocks Insiders Are Buying in October
05:56pm, Thursday, 20'th Oct 2022
According to the Insider Cluster Buys screen, a Premium feature of GuruFocus, five stocks that had a high number of company insiders buying shares over the past month were CNB Financial Corp. ( CCNE ,
3 Best Penny Stocks To Buy Before November According To Insiders
10:59am, Thursday, 20'th Oct 2022
Penny stocks to buy according to insiders in October. The post 3 Best Penny Stocks To Buy Before November According To Insiders appeared first on Penny Stocks to Buy, Picks, News and Information | Pen
10 Top Penny Stocks To Buy According To Wall Street Analysts In 2022
02:12pm, Wednesday, 19'th Oct 2022
Penny stocks to buy according to analysts in 2022. The post 10 Top Penny Stocks To Buy According To Wall Street Analysts In 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | Pe
Cabaletta Bio to Present at the 29th Annual Congress of the European Society of Gene & Cell Therapy
08:00am, Thursday, 06'th Oct 2022
PHILADELPHIA, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery and development of targeted cell therapies for patie
Cabaletta Bio to Present Data at the 31st EADV Congress and Provides Update on DesCAARTes™ Trial
01:58pm, Monday, 29'th Aug 2022
PHILADELPHIA, Aug. 29, 2022 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery and development of targeted cell therapies for patie
4 Hot Penny Stocks To Watch This Week
03:31pm, Monday, 22'nd Aug 2022
Penny stocks to add to your watch list this week. The post 4 Hot Penny Stocks To Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
What Makes Cabaletta Bio, Inc. (CABA) a New Buy Stock
01:32pm, Thursday, 09'th Jun 2022
Cabaletta Bio, Inc. (CABA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Cabaletta Bio's Updated Interim DSG3-CAART Data Fails To Cheer Investors
01:04pm, Wednesday, 18'th May 2022
Cabaletta Bio Inc (NASDAQ: CABA) presented updated data from the DesCAARTes trial, evaluating DSG3-CAART in adults with mucosal-dominant pemphigus vulgaris (mPV), a blistering skin disease that aff
Cabaletta Bio to Present at the 21st Annual Needham Virtual Healthcare Conference
08:00am, Wednesday, 06'th Apr 2022
PHILADELPHIA, April 06, 2022 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery and development of targeted cell therapies for pati
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Cabaletta Investors of a Lead Plaintiff Deadline of April 29, 2022
11:00am, Monday, 07'th Mar 2022 PR Newswire
NEW YORK, March 7, 2022 /PRNewswire/ -- Attention Cabaletta Bio, Inc. ("Cabaletta") (NASDAQ: CABA) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors. This lawsuit is on behalf of persons and entities that purchased or…
